Supports immune function, reduces oxidative stress, and may improve overall symptom burden in chronic allergic and inflammatory conditions when used alongside standard medical therapy
Neuron 99:315328
Both compounds would benefit significantly from independent replication, chronic safety studies, and -- if warranted by safety data -- carefully designed early human studies
Regulatory acceptance varies by region, with formal approval in certain therapeutic settings and off-label use prevalent in others under clinical supervision
40 In contrast, NO not only antagonizes the effects of AT-II on vascular tone, cell growth and renal sodium excretion but also downregulates the synthesis of ACE and the expression of AT 1 receptors
GLOW is often considered when: tendinopathy has persisted despite physical therapy pain improves but strength or stability does not return flare-ups occur with relatively low loads imaging shows degeneration rather than acute rupture In these cases, GLOW supports the repair environment, organizes remodeling, and helps rebuild collagen quality over time
